call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Ai In Cancer Diagnostics Market
Inquire Before Buying Request for Sample

Ai In Cancer Diagnostics Market

Home Healthcare And Pharmaceutical Ai In Cancer Diagnostics Market

AI in Cancer Diagnostics Market, By Component (Software Solutions, Hardware, Services); By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others); By End User (Hospital, Surgical Centers & Medical Institutes, Others); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)), Global Trend Analysis, Competitive Landscape & Forecast, 2019–2030

  • Published Date: November 2024
  • Report ID: BWC24905
  • Available Format: PDF
  • Page: 521

Report Overview

Rising cancer prevalence, advancements in AI technologies, increased healthcare investment, demand for early detection, and integration of AI in imaging systems drive the growth of Global AI in Cancer Diagnostics Market during the forecast period between 2024 and 2030.

Global AI in Cancer Diagnostics Market – Industry Trends & Forecast Report, 2030

Global AI in Cancer Diagnostics Market size by value was estimated at USD 643.3 million in 2023. During the forecast period between 2024 and 2030, Global AI in Cancer Diagnostics Market size is expected to expand at a robust CAGR of 34.60% reaching a value of USD 5,094.9 million by 2030. Global AI in Cancer Diagnostics Market is driven by the rising prevalence of cancer, increasing demand for early and accurate diagnosis, and advancements in AI technologies. The shortage of healthcare professionals, especially in radiology and pathology, is also a significant factor. Additionally, growing government initiatives, collaborations between tech companies and healthcare providers, and increasing patient awareness about AI's benefits are propelling market growth.

AI in Cancer Diagnostics Market

AI in Cancer Diagnostics – Overview

AI in cancer diagnostics leverages machine learning and deep learning algorithms to analyze vast amounts of medical data, including imaging (CT scans, MRIs), pathology slides, genetic information, and clinical records. By recognizing patterns and identifying potential signs of cancer, AI assists radiologists, pathologists, and oncologists in making more accurate and timely diagnoses. This technology enhances early detection, improves patient outcomes, and supports personalized treatment plans, transforming cancer care.

Global AI in Cancer Diagnostics Market

Growth Drivers

Enhanced Diagnostic Accuracy

Global AI in Cancer Diagnostics Market is significantly driven by enhanced diagnostic accuracy. AI algorithms analyze large datasets, including medical images and clinical records, with greater precision and speed than traditional methods. The improved accuracy in detecting cancer at early stages leads to better patient outcomes and lower healthcare costs. By reducing human error and providing more consistent results, AI technology is gaining trust and adoption among healthcare providers worldwide.

Data Quality and Quantity

A major restraint for the growth of Global AI in Cancer Diagnostics Market is the lack of standardized, comprehensive, and diverse data. AI algorithms require large volumes of high-quality data to accurately identify patterns and predict outcomes. Insufficient or poor-quality data can lead to inaccurate diagnoses and hinder the effectiveness of AI tools. Ensuring access to diverse and well-curated datasets is crucial for the advancement and reliability of AI in cancer diagnostics.

Impact of Escalating Geopolitical Tensions on Global AI in Cancer Diagnostics Market

Escalating geopolitical tensions could significantly impact Global AI in Cancer Diagnostics Market. Political, economic, and trade tensions and snactions could disrupt international collaborations and data sharing, which are crucial for AI development and validation. Trade restrictions and economic sanctions may limit access to advanced technologies and resources, hindering innovation. Additionally, political instability can deter investments in healthcare technology, slowing market growth. Ensuring global cooperation and stable geopolitical relations is essential for the continued advancement and widespread adoption of AI in cancer diagnostics.

Global AI in Cancer Diagnostics Market

Segmental Coverage

Global AI in Cancer Diagnostics Market – By Component

By component, Global AI in Cancer Diagnostics Market is divided into Software Solutions, Hardware, and Services segments. The software solutions segment emerges as the largest component in Global AI in Cancer Diagnostics Market. Software’s dominance is driven by the increasing adoption of AI-powered diagnostic tools for image analysis, biomarker detection, and risk assessment, enhancing diagnostic accuracy and efficiency. The integration of advanced algorithms into healthcare systems and growing investments in software innovations contribute significantly to its market share. Software solutions also enable scalable, cost-effective applications across diverse cancer types, further reinforcing their leadership in the market.

AI in Cancer Diagnostics Market Size

Global AI in Cancer Diagnostics Market – By Cancer Type

Based on cancer type, Global AI in Cancer Diagnostics Market is divided into Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and other segments. The breast cancer segment holds the largest share of Global AI in Cancer Diagnostics Market by cancer type, due to the high prevalence of breast cancer globally, advancements in imaging technologies, and the increasing adoption of AI-powered diagnostic tools to improve early detection and treatment planning. AI systems provide enhanced accuracy and efficiency in identifying anomalies, significantly reducing diagnostic errors. The growing awareness and government initiatives promoting early breast cancer screening further contribute to this segment's leadership in the market.

AI in Cancer Diagnostics Market Share

Global AI in Cancer Diagnostics Market – By End User

On the basis of end user, Global AI in Cancer Diagnostics Market is divided into Hospitals, Surgical Centers & Medical Institutes, and other segments. The hospital segment is the largest end user in Global AI in Cancer Diagnostics Market, due to hospitals’ significant adoption of advanced AI-based diagnostic tools, extensive patient base, and integration of innovative technologies for early cancer detection and personalized treatment. These facilities benefit from government funding and collaborations with AI solution providers, enhancing their diagnostic capabilities. Hospitals’ focus on improving diagnostic accuracy and reducing waiting times further contributes to their leading position in the market.

AI in Cancer Diagnostics Market Growth

Global AI in Cancer Diagnostics Market – By Region

Geographically, Global AI in Cancer Diagnostics Market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), and Middle East and Africa (MEA). North America is the leading region of Global AI in Cancer Diagnostics Market. This dominance is attributed to advanced healthcare infrastructure, high adoption of AI technologies, and significant investments in cancer research. The region also benefits from a strong presence of leading AI and healthcare companies, coupled with favorable government initiatives to promote AI in medical diagnostics. North America’s leadership reflects its robust capabilities in integrating AI into oncology for enhanced diagnostic accuracy and personalized treatment plans.

AI in Cancer Diagnostics Market Analysis

Competitive Landscape

Key players in the highly competitive Global AI in Cancer Diagnostics Market include Ibex Medical Analytics, Paige AI, PathAI, Tempus, Freenome, Enlitic, CureMetrix, Owkin, DeepBio, AIRA Matrix, Indica Labs, and Mindpeak. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In April 2023 – Scientists from the Massachusetts Institute of Technology (MIT) and the Mass General Cancer Center announced the development of Sybil, an AI tool to detect early signs of lung cancer

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2023

Base Year – 2023

Estimated Year – 2024

Forecast Period – 2024–2030

Facts Covered

Revenue in USD Million 

Market Coverage

North America (United States, Canada); Europe (Germany, United Kingdom, France, Italy, Spain, Belgium, Russia, The Netherlands, Rest of Europe); Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific); Latin America (Brazil, Mexico, Argentina, Peru, Rest of Latin America); Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East & Africa)

Product/Service Segmentation

Component, Cancer Type, End User, Region

Key Players

Ibex Medical Analytics, Paige AI, PathAI, Tempus, Freenome, Enlitic, CureMetrix, Owkin, DeepBio, AIRA Matrix, Indica Labs, Mindpeak

 

By Component

  • Software Solutions

  • Hardware

  • Services

By Cancer Type

  • Breast Cancer

  • Lung Cancer

  • Prostate Cancer

  • Colorectal Cancer

  • Brain Tumor

  • Others

By End User

  • Hospitals

  • Surgical Centers and Medical Institutes

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global AI in Cancer Diagnostics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Enhanced Diagnostic Accuracy
        2. Early Detection and Prevention
        3. Personalized Medicine
      2. Restraints
        1. Data Quality and Quantity
        2. Ethical Considerations and Bias
      3. Opportunities
        1. Increased Efficiency and Reduced Costs
        2. Growing Investment and Regulatory Support
      4. Challenges
        1. High Cost of Implementation
        2. Lack of Clinical Validation and Adoption
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global AI in Cancer Diagnostics Market: Marketing Strategies
  5. Global AI in Cancer Diagnostics Market: Geographical Analysis
    1. Global AI in Cancer Diagnostics Market, Geographical Analysis, 2023
    2. Global AI in Cancer Diagnostics Market, Market Attractiveness Analysis, 2024–2030
  6. Global AI in Cancer Diagnostics Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
        1. Software Solutions
        2. Hardware
        3. Services
      2. By Cancer Type
        1. Breast Cancer
        2. Lung Cancer
        3. Prostate Cancer
        4. Colorectal Cancer
        5. Brain Tumor
        6. Others
      3. By End User
        1. Hospitals
        2. Surgical Centers & Medical Institutes
        3. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  7. North America AI in Cancer Diagnostics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
      2. By Cancer Type
      3. By End User
      4. By Country
        1. United States
          1. By Component
          2. By Cancer Type
          3. By End User
        2. Canada
          1. By Component
          2. By Cancer Type
          3. By End User
  8. Europe AI in Cancer Diagnostics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
      2. By Cancer Type
      3. By End User
      4. By Country
        1. Germany
          1. By Component
          2. By Cancer Type
          3. By End User
        2. United Kingdom
          1. By Component
          2. By Cancer Type
          3. By End User
        3. Italy
          1. By Component
          2. By Cancer Type
          3. By End User
        4. France
          1. By Component
          2. By Cancer Type
          3. By End User
        5. Spain
          1. By Component
          2. By Cancer Type
          3. By End User
        6. Belgium
          1. By Component
          2. By Cancer Type
          3. By End User
        7. Russia
          1. By Component
          2. By Cancer Type
          3. By End User
        8. The Netherlands
          1. By Component
          2. By Cancer Type
          3. By End User
        9. Rest of Europe
          1. By Component 
          2. By Cancer Type
          3. By End User
  9. Asia Pacific AI in Cancer Diagnostics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
      2. By Cancer Type
      3. By End User
      4. By Country
        1. China
          1. By Component
          2. By Cancer Type
          3. By End User
        2. India
          1. By Component
          2. By Cancer Type
          3. By End User
        3. Japan
          1. By Component
          2. By Cancer Type
          3. By End User
        4. South Korea
          1. By Component
          2. By Cancer Type
          3. By End User
        5. Australia & New Zealand
          1. By Component
          2. By Cancer Type
          3. By End User
        6. Indonesia
          1. By Component
          2. By Cancer Type
          3. By End User
        7. Malaysia
          1. By Component
          2. By Cancer Type
          3. By End User
        8. Singapore
          1. By Component
          2. By Cancer Type
          3. By End User
        9. Vietnam
          1. By Component
          2. By Cancer Type
          3. By End User
        10. Rest of APAC
          1. By Component
          2. By Cancer Type
          3. By End User
  10. Latin America AI in Cancer Diagnostics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
      2. By Cancer Type
      3. By End User
      4. By Country
        1. Brazil
          1. By Component
          2. By Cancer Type
          3. By End User
        2. Mexico
          1. By Component
          2. By Cancer Type
          3. By End User
        3. Argentina
          1. By Component
          2. By Cancer Type
          3. By End User
        4. Peru
          1. By Component
          2. By Cancer Type
          3. By End User
        5. Rest of LATAM
          1. By Component
          2. By Cancer Type
          3. By End User
  11. Middle East & Africa AI in Cancer Diagnostics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Component
      2. By Cancer Type
      3. By End User
      4. By Country
        1. Saudi Arabia
          1. By Component
          2. By Cancer Type
          3. By End User
        2. UAE
          1. By Component
          2. By Cancer Type
          3. By End User
        3. Qatar
          1. By Component
          2. By Cancer Type
          3. By End User
        4. Kuwait
          1. By Component
          2. By Cancer Type
          3. By End User
        5. South Africa
          1. By Component
          2. By Cancer Type
          3. By End User
        6. Nigeria
          1. By Component
          2. By Cancer Type
          3. By End User
        7. Algeria
          1. By Component
          2. By Cancer Type
          3. By End User
        8. Rest of MEA
          1. By Component
          2. By Cancer Type
          3. By End User
  12. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global AI in Cancer Diagnostics Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  13. Global AI in Cancer Diagnostics Market: Import & Export
  14. Impact of Escalating Geopolitical Tensions on Global AI in Cancer Diagnostics Market
  15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Ibex Medical Analytics
    2. Paige AI
    3. PathAI
    4. Tempus
    5. Freenome
    6. Enlitic
    7. CureMetrix
    8. Owkin
    9. DeepBio
    10. AIRA Matrix
    11. Indica Labs
    12. Mindpeak
    13. Other Prominent Players
  16. Key Strategic Recommendations
  17. Research Methodology
    1.       Qualitative Research
      1.   Primary & Secondary Research
    2.       Quantitative Research
    3.       Market Breakdown & Data Triangulation
      1.   Secondary Research
      2.   Primary Research
    4.       Breakdown of Primary Research Respondents, By Region
    5.       Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Global AI in Cancer Diagnostics Segmentation

Figure 2       Global AI in Cancer Diagnostics Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Global AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 5       Global AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 6       Global AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 7       Global AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 8       Global AI in Cancer Diagnostics Market Share, By Region, By Value, 2019–2030

Figure 9       North America AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 10     North America AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 11     North America AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 12     North America AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 13     North America AI in Cancer Diagnostics Market Share, By Country, By Value, 2019–2030

Figure 14     United States AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 15     United States AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 16     United States AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 17     United States AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 18     Canada AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 19     Canada AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 20     Canada AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 21     Canada AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 22     Europe AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 23     Europe AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 24     Europe AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 25     Europe AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 26     Europe AI in Cancer Diagnostics Market Share, By Country, By Value, 2019–2030

Figure 27     Germany AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 28     Germany AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 29     Germany AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 30     Germany AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 31     United Kingdom AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 32     United Kingdom AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 33     United Kingdom AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 34     United Kingdom AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 35     Italy AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 36     Italy AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 37     Italy AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 38     Italy AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 39     France AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 40     France AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 41     France AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 42     France AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 43     Spain AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 44     Spain AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 45     Spain AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 46     Spain AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 47     Belgium AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 48     Belgium AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 49     Belgium AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 50     Belgium AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 51     Russia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 52     Russia AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 53     Russia AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 54     Russia AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 55     The Netherlands AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 56     The Netherlands AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 57     The Netherlands AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 58     The Netherlands AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 59     Rest of Europe AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 60     Rest of Europe AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 61     Rest of Europe AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 62     Rest of Europe AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 63     Asia Pacific AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 64     Asia Pacific AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 65     Asia Pacific AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 66     Asia Pacific AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 67     Asia Pacific AI in Cancer Diagnostics Market Share, By Country, By Value, 2019–2030

Figure 68     China AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 69     China AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 70     China AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 71     China AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 72     India AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 73     India AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 74     India AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 75     India AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 76     Japan AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 77     Japan AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 78     Japan AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 79     Japan AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 80     South Korea AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 81     South Korea AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 82     South Korea AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 83     South Korea AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 84     Australia & New Zealand AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 85     Australia & New Zealand AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 86     Australia & New Zealand AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 87     Australia & New Zealand AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 88     Indonesia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 89     Indonesia AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 90     Indonesia AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 91     Indonesia AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 92     Malaysia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 93     Malaysia AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 94     Malaysia AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 95     Malaysia AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 96     Singapore AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 97     Singapore AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 98     Singapore AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 99     Singapore AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 100   Vietnam AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 101   Vietnam AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 102   Vietnam AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 103   Vietnam AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 104   Rest of APAC AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 105   Rest of APAC AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 106   Rest of APAC AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 107   Rest of APAC AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 108   Latin America AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 109   Latin America AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 110   Latin America AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 111   Latin America AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 112   Latin America AI in Cancer Diagnostics Market Share, By Country, By Value, 2019–2030

Figure 113   Brazil AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 114   Brazil AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 115   Brazil AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 116   Brazil AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 117   Mexico AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 118   Mexico AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 119   Mexico AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 120   Mexico AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 121   Argentina AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 122   Argentina AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 123   Argentina AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 124   Argentina AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 125   Peru AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 126   Peru AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 127   Peru AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 128   Peru AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 129   Rest of LATAM AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 130   Rest of LATAM AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 131   Rest of LATAM AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 132   Rest of LATAM AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 133   Middle East and Africa AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 134   Middle East and Africa AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 135   Middle East and Africa AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 136   Middle East and Africa AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 137   Middle East and Africa AI in Cancer Diagnostics Market Share, By Country, By Value, 2019–2030

Figure 138   Saudi Arabia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 139   Saudi Arabia AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 140   Saudi Arabia AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 141   Saudi Arabia AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 142   UAE AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 143   UAE AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 144   UAE AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 145   UAE AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 146   Qatar AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 147   Qatar AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 148   Qatar AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 149   Qatar AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 150   Kuwait AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 151   Kuwait AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 152   Kuwait AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 153   Kuwait AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 154   South Africa AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 155   South Africa AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 156   South Africa AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 157   South Africa AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 158   Nigeria AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 159   Nigeria AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 160   Nigeria AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 161   Nigeria AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 162   Algeria AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 163   Algeria AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 164   Algeria AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 165   Algeria AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

Figure 166   Rest of MEA AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030

Figure 167   Rest of MEA AI in Cancer Diagnostics Market Share, By Component, By Value, 2019–2030

Figure 168   Rest of MEA AI in Cancer Diagnostics Market Share, By Cancer Type, By Value, 2019–2030

Figure 169   Rest of MEA AI in Cancer Diagnostics Market Share, By End User, By Value, 2019–2030

 

List of Tables

 

Table 1        Global AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 2        Global AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 3        Global AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 4        Global AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 5        Global AI in Cancer Diagnostics Market Size, By Region, By Value, 2019–2030         

Table 6        North America AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 7        North America AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 8        North America AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 9        North America AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 10      North America AI in Cancer Diagnostics Market Size, By Country, By Value, 2019–2030 

Table 11      United States AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 12      United States AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 13      United States AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 14      United States AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 15      Canada AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 16      Canada AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 17      Canada AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 18      Canada AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 19      Europe AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 20      Europe AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 21      Europe AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 22      Europe AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 23      Europe AI in Cancer Diagnostics Market Size, By Country, By Value, 2019–2030         

Table 24      Germany AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 25      Germany AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 26      Germany AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 27      Germany AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 28      United Kingdom AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 29      United Kingdom AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 30      United Kingdom AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 31      United Kingdom AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 32      Italy AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 33      Italy AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 34      Italy AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 35      Italy AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 36      France AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 37      France AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 38      France AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 39      France AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 40      Spain AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 41      Spain AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 42      Spain AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 43      Spain AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 44      Belgium AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 45      Belgium AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 46      Belgium AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 47      Belgium AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 48      Russia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 49      Russia AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 50      Russia AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 51      Russia AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 52      The Netherlands AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 53      The Netherlands AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 54      The Netherlands AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 55      The Netherlands AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 56      Rest of Europe AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 57      Rest of Europe AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 58      Rest of Europe AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 59      Rest of Europe AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 60      Asia Pacific AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 61      Asia Pacific AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 62      Asia Pacific AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 63      Asia Pacific AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 64      Asia Pacific AI in Cancer Diagnostics Market Size, By Country, By Value, 2019–2030         

Table 65      China AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 66      China AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 67      China AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 68      China AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 69      India AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 70      India AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 71      India AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 72      India AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 73      Japan AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 74      Japan AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 75      Japan AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 76      Japan AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 77      South Korea AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 78      South Korea AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 79      South Korea AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 80      South Korea AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 81      Australia & New Zealand AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030       

Table 82      Australia & New Zealand AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030

Table 83      Australia & New Zealand AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030

Table 84      Australia & New Zealand AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030

Table 85      Indonesia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 86      Indonesia AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 87      Indonesia AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 88      Indonesia AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 89      Malaysia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 90      Malaysia AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 91      Malaysia AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 92      Malaysia AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 93      Singapore AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 94      Singapore AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 95      Singapore AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 96      Singapore AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 97      Vietnam AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 98      Vietnam AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 99      Vietnam AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 100    Vietnam AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 101    Rest of APAC AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 102    Rest of APAC AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 103    Rest of APAC AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 104    Rest of APAC AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 105    Latin America AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 106    Latin America AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 107    Latin America AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 108    Latin America AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 109    Latin America AI in Cancer Diagnostics Market Size, By Country, By Value, 2019–2030 

Table 110    Brazil AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 111    Brazil AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 112    Brazil AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 113    Brazil AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 114    Mexico AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 115    Mexico AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 116    Mexico AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 117    Mexico AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 118    Argentina AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 119    Argentina AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 120    Argentina AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 121    Argentina AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 122    Peru AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 123    Peru AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 124    Peru AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 125    Peru AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 126    Rest of LATAM AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 127    Rest of LATAM AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 128    Rest of LATAM AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 129    Rest of LATAM AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 130    Middle East and Africa AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 131    Middle East and Africa AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030

Table 132    Middle East and Africa AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030

Table 133    Middle East and Africa AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 134    Middle East and Africa AI in Cancer Diagnostics Market Size, By Country, By Value, 2019–2030 

Table 135    Saudi Arabia AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 136    Saudi Arabia AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 137    Saudi Arabia AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 138    Saudi Arabia AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 139    UAE AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 140    UAE AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 141    UAE AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 142    UAE AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 143    Qatar AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 144    Qatar AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 145    Qatar AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 146    Qatar AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 147    Kuwait AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 148    Kuwait AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 149    Kuwait AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 150    Kuwait AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 151    South Africa AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 152    South Africa AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 153    South Africa AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 154    South Africa AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 155    Nigeria AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 156    Nigeria AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 157    Nigeria AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 158    Nigeria AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 159    Algeria AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030         

Table 160    Algeria AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030         

Table 161    Algeria AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030         

Table 162    Algeria AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030         

Table 163    Rest of MEA AI in Cancer Diagnostics Market Size, By Value (USD Million), 2019–2030 

Table 164    Rest of MEA AI in Cancer Diagnostics Market Size, By Component, By Value, 2019–2030 

Table 165    Rest of MEA AI in Cancer Diagnostics Market Size, By Cancer Type, By Value, 2019–2030 

Table 166    Rest of MEA AI in Cancer Diagnostics Market Size, By End User, By Value, 2019–2030 

Table 167    Ibex Medical Analytics Company Overview

Table 168    Ibex Medical Analytics Financial Overview

Table 169    Paige AI Company Overview

Table 170    Paige AI Financial Overview

Table 171    PathAI Company Overview

Table 172    PathAI Financial Overview

Table 173    Tempus Company Overview

Table 174    Tempus Financial Overview

Table 175    Freenome Company Overview

Table 176    Freenome Financial Overview

Table 177    Enlitic Company Overview

Table 178    Enlitic Financial Overview

Table 179    CureMetrix Company Overview

Table 180    CureMetrix Financial Overview

Table 181    Owkin Company Overview

Table 182    Owkin Financial Overview

Table 183    DeepBio Company Overview

Table 184    DeepBio Financial Overview

Table 185    AIRA Matrix Company Overview

Table 186    AIRA Matrix Financial Overview

Table 187    Indica Labs Company Overview

Table 188    Indica Labs Financial Overview

Table 189    Mindpeak Company Overview

Table 190    Mindpeak Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global AI in Cancer Diagnostics Market size by value was estimated at USD 643.3 million in 2023.
Ans: Global AI in Cancer Diagnostics Market by value is expected to grow at a CAGR of 34.60% during the forecast period between 2024 and 2030.
Ans: Global AI in Cancer Diagnostics Market size is forecast to reach a value of USD 5,094.9 million by 2030.
Ans: Growth of Global AI in Cancer Diagnostics Market is primarily driven by rising cancer prevalence, advancements in AI technologies, increased healthcare investment, demand for early detection, and integration of AI in imaging systems.
Ans: Key players in Global AI in Cancer Diagnostics Market include Ibex Medical Analytics, Paige AI, PathAI, Tempus, Freenome, Enlitic, CureMetrix, Owkin, DeepBio, AIRA Matrix, Indica Labs, and Mindpeak.
Ans: Hospitals account for the largest market share of Global AI in Cancer Diagnostics Market by end user.
Ans: North America holds the leadership position in Global AI in Cancer Diagnostics Market. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1733278751)
}